Professor Cherrie Galletly

Professor Cherrie Galletly
 Position Professor
 Org Unit Medical Specialties
 Email cherrie.galletly@adelaide.edu.au
 Telephone +61 8 8269 8144
 Location 33 Park Terrace-Gilberton SA 5081 ,   The Adelaide Clinic
  • Biography/ Background

    Professor Cherrie Galletly is a consultant psychiatrist working across the University, public mental health and private sectors. She takes a collaborative approach to research, with the ultimate goal of improving the quality of care for people with severe mental illness. Her research interests include schizophrenia and other psychotic disorders; she was Northern Adelaide site director for the Second National Survey of Psychosis (2010) a landmark study of more than 1800 people with psychoses. She heads up one of the leading national centres on neurostimulation treatments for psychiatric disorders. Her teaching responsibilities include the role of Course Convenor for Year 6 MBBS. She has 3 current and 6 completed PhD higher students. She is a Regional Director of postgraduate psychiatry training (Northern Area Local Health Network).

     

    She led the writing of the RANZCP Clinical Practise Guidelines for Schizophrenia and Related Disorders. She is an Associate Editor for the Australian and New Zealand Journal of Psychiatry and a member of the Editorial Executive for Australian Prescriber.She is a member of the NHMRC Mental Health Research Advisory Committee (2018).

     

    She has published more than 200 papers in the peer reviewed literature, one book and 3 book chapters, and over 50 other articles and abstracts. Her total collaborative research funding exceeds $7m.

     

    Current Positions

     

    Professor of Psychiatry –Acting Head of Discipline of Psychiatry. Chair jointly funded by University of Adelaide and Ramsay Health Care (SA) Mental Health.

     

    Regional Director of Training, Northern Adelaide Local Health Network

  • Qualifications

    2003 Doctor of Philosophy (PhD), Flinders University, South Australia

    1984 Fellow, Royal Australian and New Zealand College of Psychiatrists

    1981 Member, Royal Australian and New Zealand College of Psychiatrists

    1980 Diploma in Psychological Medicine (DPM), University of Otago, New Zealand

    1975 Bachelor of Medicine and Surgery (MBChB), University of Otago, New Zealand

  • Teaching Interests

    Teaching

    Undergraduate

    Course Advisor Year 6 MBBS

    Higher Degree 
    3 current PhD students

    Completions: 6 PhD, 6 Masters, 5 Honours students

     

    Postgraduate
    Regional Director of Training (RANZCP training program), Northern Adelaide Local Health Network

    Member of SA Branch Psychiatry Training Committee

  • Research Interests

    Current Research Projects

    Second National Survey of Psychosis (2010): This federally funded study involved 8 sites; Professor Galletly was involved in the planning and execution of this major national project. She is participating in the analysis and dissemination of this data, including a local 5 year follow-up study. She heads the cardiometabolic writing group and supervises three PhD students working on this project.

     

    Stopping the run-around: comorbidity action in the north: This study is funded by an ARC Partnership Grant and uses participatory action methods to investigate services for people with comorbid and alcohol and mental health disorders. Two PhD students are researching the Aboriginal and Refugee aspects of this project.

     

    Childhood cognitive antecedents of adult psychopathology: follow up of the Port Pirie lead cohort into adulthood: NHMRC funded study, data collection of this cohort 25 years after the original study has been completed.

     

    The Cognitive and Affective Symptoms of Schizophrenia Intervention (CASSI) Trial: double-blind cross-over trial of raloxifene in people with schizophrenia; investigates the genetic and clinical aspects of the use of oestrogen receptor modulators in schizophrenia.

     

    Telomere erosion in schizophrenia: examining lifestyle factors, oxidative stress and telomere length in people with schizophrenia.

     

    Sleep disorders in schizophrenia: uses home sleep studies to investigate the nature, prevalence and treatment of sleep disorders in people with schizophrenia.

    Metacognitive treatment for delusions in people with schizophrenia: uses cognitive therapies to address the cognitive biases that underlie delusional beliefs.

     

    Health literacy in people with mental illness: a comparison of health literacy in people with mental illness in the USA and Australia: builds on previous local health literacy research.

     

    Medication compliance in people with schizophrenia: utilises qualitative research methods to investigate the reasons people with schizophrenia stop their medication.

     

    Neurostimulation Research Group: multiple projects on ECT and rTMS, based in the private sector.

  • Research Funding

    NHMRC Grants

    National Health and Medical Research Council (NHRMC), Australia: 1098442; Castle, D., Rossell, S., Galletly, C., Harris, A., Francies, P., Siskind, D.; Project Grant; Title: “N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial”; Funds: $981,788.85; 2016-2019.

    National Health and Medical Research Council (NHRMC), Australia: 1102628; Morgan, V., McGrath, J., Galletly, C., Harvey, C., Castle, D., Cohen, M., Jablensky, A., Carr, V., Neil, A., Wattereus, A.; Project Grant; Title: “An empirical framework for assessing mortality and morbidity in people with psychotic disorders: 7-year prospective and 10-year retrospective follow-up of 2075 participants in the Survey of High Impact Psychosis (SHIP) using linked registers”; Funds: $626,179; 2016-2020.

    ARC Linkage Grant (2011-2013) 

    Australian Research Council, Australia: LP110100087; de Crespigny CF, Galletly C, Athanasos P, Procter NG, Moss JR, Rowlands CE, Liu DT, Tyllis P, Chong AJ, Lee D; Linkage Grant; Title: “Stopping the run-around: comorbidity action in the north (CAN)” ; Funds : $275,820; 2011-2013.

    Grant Assessor

    Member of NHMRC Panels for Project Grants and Practitioner Fellowships

    Project Grant Assessor for NHMRC; member of Project Grants Peer Review Honour Roll

    ARC Grant Assessor - Linkage Projects, Early Career Research Awards

    Ontario Mental Health Foundation

    The Chief Scientist Office Project Grant Scheme, Scottish Government

  • Publications

    Publications in the Last 5 Years:

     Jacomb, I, Stanton, C, Vasudevan, R, Powell, H, O'Donnell, M, Lenroot, R, Bruggemann, J, Balzan, R, Galletly, C, Liu, D, Weickert, CS, Weickert TW. (2018). C-Reactive Protein: Higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Frontiers in Immunology, 9, 1-16.

    Rosenich, E, Gill, S, Clarke, P, Paterson, T, Hahn, L, Galletly, C. (2018). Does rTMS reduce depressive symptoms in young people who have not responded to antidepressants? Early Intervention in Psychiatry. doi: 1111/eip.12743.

    Weickert, C, Cai, H, Catts, V, Webster, M, Galletly, C, Liu, D, O'Donnell, M, Weickert, T. (2018). Increased macrophages and brain endothelial cell gene expression changes in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry. doi: 10.1038/s41380-018-1235-x.

    Galletly, C, Suetani, S, Dark, F. (2018). Medication discontinuation clinics for people with psychosis: Thinking about the offset of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 52, 819-821.

    Yolland, COB, Pjillipou, A, Castle, DJ, Neill, E, Hughes, ME, Galletly, C, Smith, ZM, Francis, PS, Dean, OM, Sarris, J, Siskind, D, Harris, AWF, Rossell, SL. (2018). Improvement of Cognitive Function in Schizophrenia with N-Acetylcysteine: A Theoretical Review. Nutritional Neuroscience, 30, 1-10.

    Myles, H, Vincent, A, Myles, N, Adams, R, Chandratilleke, M, Liu, D, Mercer, J, Vakulin, J, Wittert, G, Galletly, C. (2018). Obstructive sleep apnoea is more prevalent in men with schizophrenia compared to general population controls: results of a matched cohort study. Australasian Psychiatry, 26, 600-603.

    Myles, N, Myles, H, Xia, S, Large, M, Kisley, S, Galletly, C, Bird, R, Siskind, D. (2018). Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatrica, doi: 10.1111/acps.12898.

    Haeney, O, Ash, D, Galletly, C. (2018). School Shootings - 'It wouldn't happen here?' Australian and New Zealand Journal of Psychiatry, 52, 405-407.

    Foley, DL, Mackinnon, A, Morgan, VA, Castle, DJ, Waterreus, A, Galletly, CA. (2018). Comorbid Diabetes and Depression in a National Sample of Adults with Psychosis. Schizophr Bull, 44, 84-92.

    Campbell, LE, Hanlon, MC, Galletly, CA, Harvey, C, Stain, H, Cohen, M, van Ravenzwaaij, D, Brown, S. (2017). Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis. Australian and New Zealand Journal of Psychiatry, 52, 435-445.

    Koblar, S, Cranwell, M, Koblar, S, Carnell, B, Galletly, C.  (2017). Developing empathy: does experience through simulation improve medical student empathy? Medical Science Educator, 28, 31-36.

    Boerrigter, D, Weickert, TW, Lenroot, R, O'Donnell, M, Galletly, C, Liu, D, Burgess, M, Cadiz, R, Jacomb, I, Catts, VS, Fillman, SG, Weickert, CS. (2017). Using Blood Cytokine Measures to Define High Inflammatory Biotype of Schizophrenia and Schizoaffective Disorder. Journal of Neuroinflammation, 14:188.

    Glass, LJ, Sinclair, D, Boerrigter, D, Naude K, Fung, SJ, Brown, D, Catts, VS, Tooney, P, O'Donnell, M, Lenroot, R, Galletly, C, Liu, D, Weickert TW, Weickert, CS. (2017). Brain antibodies in the cortex and blood of people with schizophrenia and controls. Transl Psychiatry, 7:e1192.

    Jablensky, A, Castle, DJ, Dark, F, Humberston, V, Killackey, E, Kulkarni, J, McGorry, P, Morgan, V, Nielssen, O, Tran, N, Galletly, C. (2017). The 2016 RANZCP Guidelines for the management of Schizophrenia and Related Disorders - what's next? Australasian Psychiatry, 25, 600-602.

    Castle, DJ, Galletly, CA, Dark, F, Humberstone, V, Morgan VA, Killackey, E, Kulkarni, J, McGorry, P, Nielssen, O, Tran, NT, Jablensky, A. (2017) The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders. MJA, 206(11): 501-505.

    Posselt, M, McDonald, K, Procter, N, de Crespigny, C, Galletly, C. (2017). Improving the provision of services to young people from refugee backgrounds with comorbid mental health and substance use problems: addressing the barriers. BMC Public Health, 17(1): 280.

    Nielssen, O, McGorry, P, Castle, D, Galletly, C. (2017). The RANZCP guidelines for Schizophrenia: Why is our practice so far short for our recommendations and what can we do about it? Australian and New Zealand Journal of Psychiatry, 51, 670-674.

    Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. Lancet Psychiatry, 4, 263-265.

    Galletly, C, Dhillon, VS, Liu, D, Balzan, RP, Hahn, LA, Fenech, MF. (2017). Shorter telomere length in people with schizophrenia: a preliminary study from Australia. Schizophrenia Research, 190, 46-51.

    Carnell, BL, Clarke, P, Gill, S, Galletly, CA. (2017). How effective is repetitive Transcranial Magnetic Stimulation for Bipolar Depression? Journal of Affective Disorders, 209, 270-272.

    Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. The Lancet Psychiatry, 4, 263-265.

    Allison, S, Bastiampillai, T, Galletly, C, Nance M. (2017). An Australian collaborative research network: Building the evidence for inpatient psychiatry. Australian and New Zealand Journal of Psychiatry, 51(8): 845.

    Myles, H, Myles, N, Liu, D, Adams, R, Wittert, G, Antic, NA, Galletly, C. (2017). How long will we sleep on obstructive sleep aponea in schizophrenia? Australian and New Zealand Journal of Psychiatry, 5, 95-96.

    Smith, C, Myles, H, Galletly, C. (2017). Developing a Metformin Prescribing Tool for Use in Adults with Mental Illness to Reduce Medication-Relate Weight Gain and Cardiovascular Risk. Australasian Psychiatry, 25, 387-390.

    Large, M, Galletly, C, Myles, N, Ryan, CJ, Myles, H. (2017). Known unknown and unknown unknowns in Suicide Risk Assessment: Aleatory and Epistemic uncertainty. BJ Psych Bulletin, 41, 160-163.

    Morgan, VA, Waterreus, A, Carr, V, Castle, D, Cohen, M, Harvey, C, Galletly, C, Mackinnon, A, McGorry Patrick, McGrath, JJ, Neil, AL, Saw, S, Badcock, JC, Foley, DL, Waghorn, G, Coker, S, Jablensky A. (2017). Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 51, 124-140.

    Kulkarni, J & Galletly, C. (2017). Improving safety for women in psychiatry wards. Australian and New Zealand Journal of Psychiatry, 51, 192-194.

    Rossell, SL, Francis, PS, Galletly, C, Harris, A, Siskind, D, Berk, M, Bozaoglu, K, Dark, F, Dean, O, Liu, D, Meyer, D, Neill, E, Phillipou, A, Sarris J, Castle DJ. (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry, 15;16(1): 320.

    Hahn, LA, Mackinnon, A, Foley, DL, Morgan, VA, Waterreus, A, Watts, GF, Castle, DJ, Liu, D, Galletly, CA. (2016). The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis, Schizophrenia Research, 184, 88-95.

    Galletly, C. (2016). Look who's talking? The Australian and New Zealand Journal of Psychiatry, 50, 11, 1031-1032.

    Myles, N, Large, M, Myles, H, Adams, R, Liu, D, Galletly, C. (2016). Australia's economic transition, unemployment, suicide and mental health needs, The Australian and New Zealand Journal of Psychiatry, 51, 119-123.

    Galletly,CA, Carnell,BL, Clarke,P, Gill, S. (2016). A Comparison of Right Unilateral and Sequential Bilateral Repetitive Transcranial Magnetic Stimulaiton for Major Depression: A Naturalistic Clinical Australian Study, Journal of ECT, 33, 58-62.

    Groenkjaer,M, de Crespigny,C, Liu,D, Moss,J, Cairney,I, Lee,D, Procter,N, Galletly, C. (2016). "The Chicken or the Egg": Barriers and Facilitators to Collaborative Care for People with Comorbidity in a Metropolitan Region of South Australia, Issues in Mental Health Nursing, 38, 18-24. 

    Hahn,LA, Mackinnon,A, Foley,DL, Morgan,VA, Waterreus,A, Watts,GF, Castle,DJ, Liu,D, Galletly,CA. Counting up the risks - How common are risk factors for morbidity and mortality in young people with psychosis? (2016). Early Intervention in Psychiatry, 12, 1045-1051.

    Hahn,LA, Mackinnon,A, Foley,DL, Morgan,VA, Waterreus,A, Watts,GF, Castle,DJ, Liu,D, Galletly,CA. (2016). The value of counting WHO-defined risk factors for death and disability in a national sample of adults with psychosis, Schizophrenia Research, 182, 13-18.

    Foley,DL, Mackinnon,A, Morgan,VA, Watts,GF, Castle,DJ, Waterreus,A, Galletly,CA. (2016). Common familial risk factors for schizophrenia and diabetes mellitus, Australian and New Zealand Journal of Psychiatry, 50, 5, 488-494.

    Suetani,S, Waterreus,A, Morgan,V, Foley,DL, Galletly,CA, Badcock,JC, Watts,G, McKinnon,A, Castle,D, Saha,S et al, (2016). Correlates of physical activity in people living with psychotic illness, Acta Psychiatrica Scandinavica, 2, 129-37.

    Liu,D, Myles,H, Foley,DL, Watts,GF, Morgan,VA, Castle,D, Waterreus,A, Mackinnon,A, Galletly,CA. (2016). Risk factors for obstructive sleep apnea are prevalent in people with psychosis and correlate with impaired social functioning and poor physical health, Frontiers in Psychiatry, 7, 139-1-139-12.

    Pillai,A, Howell,KR, Ahmed,AO, Weinberg,D, Allen,KM, Bruggemann,J, Lenroot,R, Liu,D, Galletly,C, Weickert, CS et al. (2016). Association of serum VEGF levels with prefrontal cortex volume in schizophrenia, Molecular Psychiatry, 21, 5, 686-692.

    Cohen,OS, Weickert,TW, Hess,JL, Paish,LM, McCoy,SY, Rothmond,DA, Galletly,C, Liu,D, Weinberg,DD, Huang,XF et al. (2016). A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples, Molecular Psychiatry, 21, 7, 975-982.

    Myles,H, Myles,N, Antic,NA, Adams,R, Chandratilleke,M, Liu,D, Mercer,J, Vakulin,A, Vincent,A, Wittert,G et al. (2016). Obstructive sleep apnea and schizophrenia: A systematic review to inform clinical practice, Schizophrenia Research, 170, 1, 222-225.

    Foley,DL, Mackinnon,A, Morgan,VA, Watts,GF, Castle,DJ, Waterreus,A, Galletly, CA. (2016). Awareness of Pre-diabetes or Diabetes and Associated Factors in People With Psychosis., Schizophrenia bulletin, 42, 5, 1280-1289.

    Morgan,VA, Morgan,F, Galletly,CA, Valuri,G, Shah,S, Jablensky,A. (2016). Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders, Social Psychiatry and Psychiatric Epidemiology, 51, 2, 269-279.

    Weinberg,D, Lenroot,R, Jacomb,I, Allen,K, Bruggemann,J, Wells,R, Balzan,R, Liu,D, Galletly,C, Catts,S et al. (2016). Cognitive subtypes in schizophrenia characterized by differential brain volumetric reductions and cognitive decline, JAMA Psychiatry.

    Liu,D, de Crespigny,C, Procter,N, Kelly,J, Francis,H, Posselt,M, Cairney,I, Galletly,C. (2016). Comorbidity Action in the North: a study of services for people with comorbid mental health and drug and alcohol disorders in the northern suburbs of Adelaide., Australasian psychiatry: bulletin of Royal Australian and New Zealand College of Psychiatrists.

    Galletly,CA, Gill,S, Rigby,A, Carnell,BL, Clarke,P. (2016). Assessing the effects of repetitive transcranial magnetic stimulation on cognition in major depressive disorder using computerized cognitive testing, Journal of ECT, 32, 169-173.

    Galletly,CA, Turnbull,C, Goldney,R. (2016). Medical student teaching in the private sector - An overlooked opportunity?, Australasian Psychiatry, 24, 2, 198-200.

    Galletly,CA, Clark,LS, McFarlane,AC, Searle,AK, Sawyer,MG, Sim,MR, Baghurst,PA, van Hooff,M. (2016). Childhood lead exposure, childhood trauma, substance use and subclinical psychotic experiences - a longitudinal cohort study, Psychiatry Research, 239, 54-61.

    Cairney,I, Galletly,C, de Crespigny,C, Liu,D, Moss,J, Procter,N. (2015). Stopping the run-around? A study of services for people with comorbid mental health and substance use disorders in northern Adelaide, Australasian Psychiatry, 23, 3, 233-235.

    Lacey,M, Paolini,S, Hanlon,MC, Melville,J, Galletly,C, Campbell,LE. (2015). Parents with serious mental illness: differences in internalised and externalised mental illness stigma and gender stigma between mothers and fathers, Psychiatry Research, 225, 3, 723-733.

    Posselt,M, Procter,N, de Crespigny,C, Galletly,C. (2015). Merging perspectives: obstacles to recovery for youth from refugee backgrounds with comorbidity, Australasian Psychiatry, 23, 3, 293-299.

    Galletly,CA. (2015). Making things better?, Australian and New Zealand Journal of Psychiatry, 49, 11, 958-959.

    Foley,DL, Mackinnon,A, Morgan,VA, Watts,GF, Castle,DJ, Waterreus,A, Galletly,CA.(2015). Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study, The Lancet Psychiatry, 2, 12, 1092-1098.

    Foley,DL, Mackinnon,A, Morgan,VA, Watts,GF, Shaw,JE, Magliano,DJ, Castle,DJ, McGrath,JJ, Waterreus,A, Galletly,CA et al. (2015). Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sample, The Australian and New Zealand Journal of Psychiatry, 49, 8, 714-723.

    Galletly,C, Castle,D, Dark,F, Humberstone,V, Jablensky,A, Killackey,E, Kulkarni,J, McGorry,P, Nielssen,O, Tran,N et al. (2015). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders, Australian and New Zealand Journal of Psychiatry, 50, 5, 410-472.

    Happell,B, Platania-Phung,C, Webster,S, McKenna,B, Millar,F, Stanton,R, Galletly,C, Castle,D, Furness,T, Liu,D et al. (2015). Applying the World Health Organization Mental Health Action Plan to evaluate policy on addressing co-occurrence of physical and mental illnesses in Australia, Australian Health Review, 39, 370-378.

    Posselt,M, Procter,N, Galletly,C, de Crespigny,C. (2015). Aetiology of coexisting mental health and alcohol and other drug disorders: perspectives of refugee youth and service providers, Australian Psychologist, 50, 2, 130-140.

    Happell,B, Galletly,C, Castle,D, Platania-Phung,C, Stanton,R, Scott,D, McKenna,B, Millar,F, Liu,D, Browne,M et al. (2015). Scoping review of research in Australia on the co-occurrence of physical and serious mental illness and integrated care, International Journal of Mental Health Nursing, 24, 5, 421-438.

    Suetani,S, Gill,S, Galletly,C. (2015). A scholarly endeavour: Some practical tips on completing the scholarly project, Australasian Psychiatry, 23, 1, 29-31.

    Badcock,JC, Shah,S, Mackinnon,A, Stain,H, Galletly,C, Jablensky,J, Morgan,VA. (2015). Loneliness in psychotic disorders and its association with cognitive function and symptom profile, Schizophrenia Research, 169, 1-3, 268-273.

    Ford,N, Ludbrook,G, Galletly,C. (2015). Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression, Australian & New Zealand Journal of Psychiatry, 49, 12, 1227-1227.

    Sweeney,S, Air,T, Zannettino,L, Galletly,CA. (2015). Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis, Frontiers in Psychology, 6, 1768-1-1768-8.

    Kisely,S, Chang,A, Crowe,J, Galletly,C, Jenkins,P, Loi,S, Looi,JC, Macfarlane,MD, McVie,N, Parker,S et al. (2015). Getting started in research: systematic reviews and meta-analyses, Australasian Psychiatry. 23, 1, 16-21.

    Clarke,P, Gill,S, Carnell,B, Galletly,C. (2015). How safe is repetitive Transcranial Magnetic Stimulation? Australian & New Zealand Journal of Psychiatry, 49, 5, 485-485.

    Weickert,TW, Weinberg,D, Lenroot,R, Catts,SV, Wells,R, Vercammen,A, O'Donnell,M, Galletly,C, Liu,D, Balzan,R et al. (2015). Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia, Molecular Psychiatry, 20, 6, 685-694.

    Galletly,CA, Loo,CK, Malhi,GS, Mitchell,PB, Fitzgerald,P. (2015). Why repetitive transcranial magnetic stimulation should be available for treatment resistant depression, Australian and New Zealand Journal of Psychiatry, 49, 2, 182-183.

    Sweeney,S, Air,T, Zannettino,L, Galletly,CA. (2015). Psychosis, socioeconomic disadvantage, and health service use in South Australia: Findings from the second, Frontiers in Public Health, 3, 1-8.

    Galletly,C, Clarke,P, Carnell,BL, Gill,S. (2015). A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on, Australian and New Zealand Journal of Psychiatry, 49, 11, 1040-1047.

    Nenke,MA, Hahn,LA, Thompson,CH, Liu,D, Galletly,CA. (2015). Psychosis and cardiovascular disease: Is diet the missing link?, Schizophrenia Research, 161, 2-3, 465-470.

    de Crespigny,C, Groenkjaer,M, Liu,D, Moss,J, Cairney,I, Procter,N, Posselt,M, Jebaraj,HSF, Schultz,T, Banders,A et al. (2015). Service provider barriers to treatment and care for people with mental health and alcohol and other drug comorbidity in a metropolitan region of South Australia, Advances in Dual Diagnosis, 8, 3, 120-128.

    Balzan,RP, Galletly,C. (2015). Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: a case study, Frontiers in Psychology, 6, 967-1-967-6.

    Galletly,CA. (2015). ANZJP Weltanschauung, Australian and New Zealand Journal of Psychiatry, 49, 8, 677-678.

    Balzan,R, Delfabbro,P, Galletly,C, Woodward,T. (2014). Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single module programme, Australian and New Zealand Journal of Psychiatry, 48, 12, 1126-1136.

    Ashton,M, Rigby,A, Galletly,C. (2014). Do population-wide tobacco control approaches help smokers with mental illness?, Australian & New Zealand Journal of Psychiatry, 48, 2, 121-123.

    Morgan,VA, McGrath,JJ, Jablensky,A, Badcock,JC, Waterreus,A, Bush,R, Carr,V, Castle,D, Cohen,M, Galletly,C et al. (2014). Psychosis prevalence and physical, metabolic and cognitive co-morbidity: Data from the second Australian national survey of psychosis, Psychological Medicine, 44, 10, 2163-2176.

    Burton,C, Gill,S, Clarke,P, Galletly,C. (2014). Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report, Archives of Women's Mental Health, 17, 3, 247-250.

    Hahn,L, Rigby,A, Galletly,C. (2014). Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia, Australian and New Zealand Journal of Psychiatry, 48, 1, 70-79.

    Galletly,C. (2014). Should lithium be added to the drinking water?, Australian & New Zealand Journal of Psychiatry, 48, 9, 793-794.

    Galletly,C, Clarke,P, Paterson,T, Rigby,A, Gill,S. (2014). Practical considerations in the use of ultrabrief ECT in clinical practice, Journal of ECT, 30, 1, 10-14.

    Shah,S, Mackinnon,A, Galletly,C, Carr,V, McGrath,JJ, Stain,HJ, Castle,D, Harvey,C, Sweeney,S, Morgan,VA et al. (2014). Prevalence and impact of childhood abuse in people with a psychotic illness. Data from the second Australian national survey of psychosis, Schizophrenia Research, 159, 1, 20-26.

    Galletly,CA. (2014). Educating psychiatrists in the post-pharma era, Andhra Pradesh Journal of Psychological Medicine, 15, 1, 10-12.

    Posselt,M, Galletly,C, de Crespigny,C, Procter, N. (2014). Mental health and drug and alcohol comorbidity in young people of refugee background: a review of the literature, Mental Health and Substance Use, 7, 1, 19-30.

    Hahn,LA, Galletly,CA, Foley,DL, Mackinnon,A, Watts,GF, Castle,DJ, Waterreus,A, Morgan,VA. (2014). Inadequate fruit and vegetable intake in people with psychosis, Australian and New Zealand Journal of Psychiatry, 48, 11, 1025-1035.

    Gill,S, Clarke,P, Rigby,A, Carnell,B, Galletly,CA. (2014). Transcranial Magnetic Stimulation and psychological therapies: Considering the benefits of a combined treatment approach for depression, World Journal of Medical Research, 3, 7, 46-53.

    Foley,DL, MacKinnon,A, Morgan,VA, Watts,GF, McGrath,JJ, Castle,DJ, Waterreus,A, Galletly,CA. (2014). Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis, World Psychiatry, 13, 2, 176-183.

    Balzan,RP, Neaves,A, Denson,LA, Liu,D, Galletly,C. (2014). Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?, COGNITIVE NEUROPSYCHIATRY, 19, 6, 471-484.

    Posselt,M, Galletly,C, de Crespigny,C, Cairney,I, Moss,J, Liu,D, Francis,H, Kelly,J, Procter,N, Banders,A et al. (2014). Ethics overload: impact of excessive ethical review on comorbidity research, Mental Health and Substance Use, 7, 3, 184-194.

    Searle,AK, Baghurst,PA, van Hooff,M, Sawyer,MG, Sim,MR, Galletly,C, Clark,LS, McFarlane,AC. (2014). Tracing the long-term legacy of childhood lead exposure: a review of three decades of the Port Pirie Cohort study, NeuroToxicology, 43, 46-56.

    Chan,WI, Batterham,P, Christensen,H, Galletly,C. (2014). Suicide literacy, suicide stigma and help-seeking intentions in Australian medical students, Australasian Psychiatry, 22, 2, 132-139.

     

  • Professional Associations

    Australian Medical Association

     

    Australian and New Zealand Association of Psychiatry, Psychology and the Law

     

     

    Collegium Internationale Neuropsychopharmacologium

     

    European Association of Threat Assessment Professionals

     

    Royal Australian & New Zealand College of Psychiatrists

     

    RANZCP Section for Neurosciences

     

    Schizophrenia International Research Society

     

  • Media Expertise

    CategoriesMedicine & Medical Research, Psychology & Psychiatry
    ExpertiseMemory; Working memory (and its effects on schizophrenia); schizophrenia among young people; schizophrenia; youth; academic psychiatry; PTSD; professional boundaries; obesity; medicolegal
    After hours0406422494

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Sunday, 17 Nov 2019

To link to this page, please use the following URL:  https://www.adelaide.edu.au/directory/cherrie.galletly